For most of this year, Amazon has been the "prove it" stock.

Every quarter came with the same objection: great business, $200 billion in AI capex, no clear payback number from management.

Then Thursday's earnings answered that question directly, and Monday the market finally believed it, sending Amazon up almost 5% and through $3 trillion in market value for the first time.

The obvious headline is the round number. I don't think that's the real story.

That's what This Week's Focus is here to dig into: what actually changed inside Amazon's numbers this week, and whether $3 trillion is a finish line or a new starting point.

Missed Monday's edition on Qualcomm?🤔 Everyone's Selling Qualcomm. I'm Not Convinced

Palantir delivered another blowout quarter, with Q2 revenue up 93% year over year to $1.94 billion, beating analyst expectations, and full-year 2026 revenue guidance lifted to around $8.15 billion. The standout was U.S. commercial demand, with Alex Karp calling the quarter “otherworldly” as AI adoption keeps accelerating across enterprise customers. The key investor takeaway is simple: Palantir’s growth story is still very real, but the stock now has to keep clearing a much higher bar.

Berkshire Hathaway’s Alphabet position has become a major signal under Greg Abel. Berkshire has now put more than $23 billion into Alphabet, helped by earlier purchases and a $10 billion private placement tied to Alphabet’s AI infrastructure funding. The interesting part is that this does not look like Berkshire chasing hype. It looks like Berkshire buying a highly profitable business where AI, Google Cloud, search, and infrastructure spending could strengthen an already powerful moat.

AbbVie’s biggest overhang, the Humira patent cliff, is starting to look much more manageable. Growth from Skyrizi and Rinvoq has helped offset Humira erosion, while the company continues to lean on its dividend, pipeline, and broader immunology strength. The takeaway is that AbbVie is no longer just a “post-Humira recovery” story. It is becoming a steadier pharma compounder again, though investors still need to watch guidance cuts, trial setbacks, and whether the replacement drugs can keep carrying the load.

The biggest IPO in history is live — $1.75T valuation, $135 open, $75B raised. And history says the retail investors who chase day-one hype are the ones who get burned.

The SpaceX run created thousands of new millionaires. But it wasn't the people buying at the open. It was the ones positioned early, in the names set to ride the wave.

Our analyst pinpointed 3 stocks positioned to ride the SpaceX wave — with entry guidance and price targets, a bonus 4th pick (the most undervalued name in the sector), and a 3-phase playbook for when to buy and when to sell.

Over 2,500 investors have already read the report. Claim your free copy here.

Get the Free Report

Amazon crossed $3 trillion in market value on Monday, becoming just the fifth company ever to do it. The stock is up nearly 5% on the day, sitting at a fresh all-time high near $287.

The obvious read is that Amazon "arrived." Big number, big milestone, a clean round trip from the AI capex scare earlier this year.

That read misses what actually happened. Amazon didn't get more expensive because of a round number. It got more expensive because one specific figure inside Thursday's earnings answered a question this newsletter has been asking since March.

The real question this week isn't whether $3 trillion is a big deal. It's whether Amazon just closed the debate around its AI spending, or whether $3 trillion just raised the bar for everything that comes next.

Back in July, I flagged one number as the entire investment debate. AWS growth needed to hit 30% or beyond in Q2 to turn the $200 billion capex story from an uncertain bet into infrastructure paying for itself.

It came in at 36.7%, the fifth straight quarter of acceleration and well past the level I said would matter.

The backlog moved just as fast. AWS's signed contract backlog jumped from $364 billion in Q1 to $496 billion in Q2, growing at a triple-digit percentage rate, and that isn't projected demand. That's revenue Amazon has already contracted to deliver.

Margins caught up too. AWS operating income hit $16.6 billion, up 64% year over year, with operating margin expanding 650 basis points to 39.4%. Total company revenue reached $200.6 billion, up 20%, and operating income jumped 43% to $27.5 billion.

That's not a company spending its way to growth. That's a company finally getting paid for the spending it already did.

Management didn't just defend the $200 billion capex number this quarter. It raised it, guiding to $220 billion for the year on continued AI-driven demand and a backlog too large to ignore.

That's a real number now, not a philosophy, which is genuine progress from where things stood in March. But it's also a bigger number, and the free cash flow pressure that came with the original $200 billion guide hasn't gone away just because AWS accelerated.

And honestly? A bigger bet backed by better evidence is still a bigger bet.

There's a pattern worth sitting with here. Apple, Microsoft, Alphabet, and Nvidia all crossed the $3 trillion mark before Amazon, and each one found the milestone easier to reach than to hold in the months right after.

A $3 trillion valuation prices in close to flawless execution from here. Any AWS deceleration, any capex overrun without a matching backlog number, and this stock has a lot further to fall than it did back at $2 trillion.

Because the market just rewarded Amazon for turning a philosophy into a number. It will punish Amazon just as fast the first time that number slips backward.

Amazon spent the back half of this year fighting its own chart. In mid-July it was pinned near $243, sitting on its 20-day moving average after an 18% pullback from May's highs, with the 50-day average around $255 acting as a lid buyers couldn't push through across three separate attempts.

Thursday's earnings broke that pattern completely. The stock ran straight through both of those levels and kept climbing, closing Monday near $287 after a nearly 5% pop that pushed it to a fresh all-time high and briefly touched $287.20 intraday.

That's a stock that spent months in a standoff between chart and business, and the business just won decisively. The next real question is whether $287 becomes the new floor the way $243 once was, or whether the first serious profit-taking after a $3 trillion milestone drags it back toward the old $255 resistance, now flipped to potential support.

Watch how it behaves on any pullback over the next few weeks. A shallow dip that gets bought quickly confirms institutions are treating this as a genuine re-rating, while a slide back below $270 would suggest Monday's move was more relief than conviction.

Amazon guided Q3 revenue to $197 billion to $202 billion. Hitting the high end would confirm the AWS acceleration is durable rather than a single strong print, while a number near the low end would reopen the capex sustainability debate almost immediately.

Amazon has guided toward negative free cash flow in 2026 because of the capex ramp. Watch the next quarterly cash flow statement closely, since a narrower-than-expected shortfall would be the clearest signal yet that the $220 billion is being spent efficiently rather than just aggressively.

I flagged this back in July. The Anthropic deal, worth more than $100 billion, wasn't yet inside AWS's backlog figure when Amazon's pullback to $243 was worth buying on the business, and part of that call rested on this exact workload eventually showing up in the numbers. Watch for early commentary on how much of that revenue has started converting from backlog to income statement.

Microsoft and Google both report cloud results on a similar cycle, and any sign of Azure or Google Cloud accelerating past AWS's 36.7% would complicate the "AWS is winning AI cloud" narrative currently powering this stock. Competitive deceleration elsewhere is part of what's being priced into Amazon right now, whether investors realize it or not.

The average Wall Street target sits near $322, with estimates ranging from $207 to $400 and not a single sell rating among 59 analysts covering the stock. Watch whether more targets cluster toward the high end after this print or whether the spread stays this wide, since a gap that large this soon after a $3 trillion milestone usually means the Street hasn't fully agreed on what happens next either.

I called this exact setup back in July, and I don't say that to take a victory lap. I say it because the logic that got us here still applies going forward.

The 30% AWS growth threshold I flagged wasn't a guess. It was the specific number that separated a capex story built on faith from one built on math, and Amazon cleared it by a wide margin.

That means the hard part of this thesis is done. The harder, and in some ways more dangerous part, is what comes next, a $3 trillion valuation that now assumes Amazon keeps clearing bars this high every single quarter.

I'm not selling into this. But I'm watching Q3 guidance a lot more closely than I'm watching the market cap headline, because that number, not this one, is what tells you whether $3 trillion actually holds.

Most coverage tells you what happened. Fintech Takes is the free newsletter that tells you why it matters. Each week, I break down the trends, deals, and regulatory shifts shaping the industry — minus the spin. Clear analysis, smart context, and a little humor so you actually enjoy reading it. Subscribe free.

Sign Up Free

Round numbers make headlines. Backlogs make theses.

Three trillion dollars is a milestone. It isn't an argument, and it never was.

The argument was always the $496 billion in signed AWS contracts sitting behind that number, the same kind of evidence that made the $243 pullback worth buying back in July.

Markets eventually price businesses correctly, but rarely on the schedule investors expect. Amazon just spent five months proving that the wait is often the actual work.

The lesson isn't really about Amazon. It's about trusting the backlog over the round number, every time the two disagree.

The best readers here were referred by readers like you. Pass it on.